El Salvador inks deal with Pfizer for 4.4 million COVID-19 vaccine doses

Outbreak of the coronavirus disease (COVID-19) in Rio de Janeiro

SAN SALVADOR (Reuters) - El Salvador's president Nayib Bukele said on Twitter on Tuesday night that the Central American nation has signed an agreement with Pfizer Inc for 4.4 million COVID-19 vaccine doses.

"With this purchase, we guarantee uninterrupted immunization for our entire target population," said Bukele.

(Reporting by Nelson Renteria; Writing by Anthony Esposito; Editing by Tom Hogue)